Efalizumab (Raptiva®), Safe and Effective in Treatment of Heavy Psoriasis Patients
August 6, 2007 by admin · Leave a Comment
Marketed by Genentech as Raptiva® - Efalizumab - a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis - has been found safe and effective for…
